Thank you, Chair.
Chair, the motions in amendments CPC-3, 4, 5, 6, 7, and 10 require the minister to make publicly available recall, reassessment, label change, and test studies orders; require the minister to make publicly available positive and negative decisions and the reasons for them; and require the therapeutic authorization holder to make prescribed information about clinical trials and investigative tests publicly available. Consequently, the intent of this motion is already covered, with the exception of a section that says “results of clinical trials and investigational tests”.
However, in amendment CPC-10, the minister gets the authority to make regulations respecting the type of information. So it would be a simple matter for the minister to create that authority by regulation through the GIC to get the results of clinical trials and investigative tests, and I'm sure that would be done.